dc.contributor.author |
Monk, Ruth |
|
dc.contributor.author |
Connor, Bronwen |
|
dc.contributor.editor |
Han, F |
|
dc.contributor.editor |
Lu, P |
|
dc.date.accessioned |
2021-08-13T02:42:07Z |
|
dc.date.available |
2021-08-13T02:42:07Z |
|
dc.date.issued |
2020-1 |
|
dc.identifier.isbn |
9789811543692 |
|
dc.identifier.uri |
https://hdl.handle.net/2292/56006 |
|
dc.description.abstract |
Huntington's disease (HD) is an inherited neurodegenerative disorder which is characterised by a triad of highly debilitating motor, cognitive, and psychiatric symptoms. While cell death occurs in many brain regions, GABAergic medium spiny neurons (MSNs) in the striatum experience preferential and extensive degeneration. Unlike most neurodegenerative disorders, HD is caused by a single genetic mutation resulting in a CAG repeat expansion and the production of a mutant Huntingtin protein (mHTT). Despite identifying the mutation causative of HD in 1993, there are currently no disease-modifying treatments for HD. One potential strategy for the treatment of HD is the development of cell-based therapies. Cell-based therapies aim to restore neuronal circuitry and function by replacing lost neurons, as well as providing neurotropic support to prevent further degeneration. In order to successfully restore basal ganglia functioning in HD, cell-based therapies would need to reconstitute the complex signalling network disrupted by extensive MSN degeneration. This chapter will discuss the potential use of foetal tissue grafts, pluripotent stem cells, neural stem cells, and somatic cell reprogramming to develop cell-based therapies for treating HD. |
|
dc.format.medium |
Print |
|
dc.publisher |
Springer Singapore |
|
dc.relation.ispartof |
Stem Cell-based Therapy for Neurodegenerative Diseases |
|
dc.relation.ispartofseries |
Advances in Experimental Medicine and Biology |
|
dc.rights |
Items in ResearchSpace are protected by copyright, with all rights reserved, unless otherwise indicated. Previously published items are made available in accordance with the copyright policy of the publisher. |
|
dc.rights.uri |
https://researchspace.auckland.ac.nz/docs/uoa-docs/rights.htm |
|
dc.subject |
Corpus Striatum |
|
dc.subject |
Neurons |
|
dc.subject |
Pluripotent Stem Cells |
|
dc.subject |
Animals |
|
dc.subject |
Humans |
|
dc.subject |
Huntington Disease |
|
dc.subject |
Disease Models, Animal |
|
dc.subject |
Fetal Tissue Transplantation |
|
dc.subject |
Neural Stem Cells |
|
dc.subject |
Cell- and Tissue-Based Therapy |
|
dc.subject |
Cellular Reprogramming |
|
dc.subject |
Huntingtin Protein |
|
dc.subject |
Animals |
|
dc.subject |
Cell- and Tissue-Based Therapy |
|
dc.subject |
Cellular Reprogramming |
|
dc.subject |
Corpus Striatum |
|
dc.subject |
Disease Models, Animal |
|
dc.subject |
Fetal Tissue Transplantation |
|
dc.subject |
Humans |
|
dc.subject |
Huntingtin Protein |
|
dc.subject |
Huntington Disease |
|
dc.subject |
Neural Stem Cells |
|
dc.subject |
Neurons |
|
dc.subject |
Pluripotent Stem Cells |
|
dc.subject |
Science & Technology |
|
dc.subject |
Life Sciences & Biomedicine |
|
dc.subject |
Medicine, Research & Experimental |
|
dc.subject |
Clinical Neurology |
|
dc.subject |
Research & Experimental Medicine |
|
dc.subject |
Neurosciences & Neurology |
|
dc.subject |
NEURAL STEM-CELLS |
|
dc.subject |
FETAL STRIATAL TRANSPLANTATION |
|
dc.subject |
UNILATERAL NEOSTRIATAL LESIONS |
|
dc.subject |
POSITRON-EMISSION-TOMOGRAPHY |
|
dc.subject |
ADULT HUMAN FIBROBLASTS |
|
dc.subject |
RAT MODEL |
|
dc.subject |
MOLECULAR PATHOGENESIS |
|
dc.subject |
SUBVENTRICULAR ZONE |
|
dc.subject |
BEHAVIORAL RECOVERY |
|
dc.subject |
DIRECT CONVERSION |
|
dc.subject |
11 Medical and Health Sciences |
|
dc.title |
Cell Replacement Therapy for Huntington's Disease. |
|
dc.type |
Book Item |
|
dc.identifier.doi |
10.1007/978-981-15-4370-8_5 |
|
pubs.begin-page |
57 |
|
pubs.volume |
1266 |
|
dc.date.updated |
2021-07-10T04:01:08Z |
|
dc.rights.holder |
Copyright: The author |
en |
pubs.author-url |
https://www.ncbi.nlm.nih.gov/pubmed/33105495 |
|
pubs.end-page |
69 |
|
pubs.publication-status |
Published |
|
dc.rights.accessrights |
http://purl.org/eprint/accessRights/RestrictedAccess |
en |
pubs.elements-id |
827296 |
|
pubs.online-publication-date |
2020-10-27 |
|